Clover (ASX:CLV) Common Stock : A$36.27 Mil (As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Clover Common Stock?

Clover's quarterly common stock stayed the same from Jan. 2023 (A$36.27 Mil) to Jul. 2023 (A$36.27 Mil) and stayed the same from Jul. 2023 (A$36.27 Mil) to Jan. 2024 (A$36.27 Mil).

Clover's annual common stock stayed the same from Jul. 2021 (A$35.60 Mil) to Jul. 2022 (A$35.60 Mil) but then increased from Jul. 2022 (A$35.60 Mil) to Jul. 2023 (A$36.27 Mil).

Clover Common Stock Historical Data

The historical data trend for Clover's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Common Stock Chart

Clover Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Common Stock

Get a 7-Day Free Trial

32.92

35.37

35.60

36.27

Clover Semi-Annual Data
	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24
Common Stock	Get a 7-Day Free Trial															35.60	35.60	36.27	36.27	36.27

Clover Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Clover (ASX:CLV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Clover Corp Ltd (ASX:CLV) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

39 Pinnacle Road, Altona North, Melbourne, VIC, AUS, 3025

Website

https://www.clovercorp.com.au

Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe, and the Americas. Majority of the revenue is derived from Asia.